Elevian, Inc.

📍 Newton, United States🗓 Founded 2018👥 14 employees💰 Last funded Aug 2021
Biotechnology Research🌐 elevian.com
Website LinkedIn
At Elevian, we are developing new medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke in the days following the event, for which there are currently no viable treatments. By promoting regeneration, Elevian’s medicines have the potential to treat and prevent many aging-associated diseases.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Sweden
1
Frequently asked questions
Who invested in Elevian, Inc.?
Elevian, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Elevian, Inc. last raise funding?
The most recent investment in Elevian, Inc. recorded on gritt.io was in August 2021.
When was Elevian, Inc. founded?
Elevian, Inc. was founded in 2018.
What industry is Elevian, Inc. in?
Elevian, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Elevian, Inc. based?
Elevian, Inc. is headquartered in Newton, United States.